Bloodstream Infections by AmpC-Producing Enterobacterales: Risk Factors and Therapeutic Outcome.

Autor: Pospišil M; Krapina-Zagorje County Community Health Centre, 49245 Stubica, Croatia., Car H; Zagreb Health School, 10000 Zagreb, Croatia., Elveđi-Gašparović V; Department of Gynecology and Obstetrics, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.; Department of Gynecology and Obstetrics, University Hospital Centre Zagreb, 10000 Zagreb, Croatia., Beader N; BIMIS-Biomedical Research Center Šalata, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.; Clinical Department for Clinical and Molecular Microbiology, University Hospital Centre Zagreb, 10000 Zagreb, Croatia., Herljević Z; Clinical Department for Clinical and Molecular Microbiology, University Hospital Centre Zagreb, 10000 Zagreb, Croatia., Bedenić B; BIMIS-Biomedical Research Center Šalata, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.; Clinical Department for Clinical and Molecular Microbiology, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
Jazyk: angličtina
Zdroj: Pathogens (Basel, Switzerland) [Pathogens] 2023 Sep 03; Vol. 12 (9). Date of Electronic Publication: 2023 Sep 03.
DOI: 10.3390/pathogens12091125
Abstrakt: Bloodstream infections associated with AmpC-producing Enterobacterales are severe medical conditions which, without prompt and effective treatment, may have dire ramifications. This study aimed to assess whether certain comorbidities and previous surgical procedures coincide with resistance determinants of AmpC-producing Enterobacterales associated with bloodstream infections. Antibiotic resistance patterns and therapy outcome were also determined. The patients' data obtained revealed that the prevalence of recent surgical procedures, solid organ tumors, metabolic diseases, kidney and liver failure, and hematological malignancies do not differ between resistant and susceptible isolates of AmpC-producing Enterobacterales. Furthermore, no difference was reported in mortality rates. Regarding antibiotic resistance, 34.52% of isolates were confirmed to be resistant (AmpC hyperproduction, ESBL, or carbapenemase). More than one in five AmpC hyperproducers were reported amid Providencia spp., K. aerogenes , E. cloacae , and C. freundii. strains. Carbapenemases were mostly noted in Providencia spp. followed by M. morganii and K. aerogenes strains. Serratia marcescens had the highest proportion of ESBLsof ESBLs. Resistance to expanded-spectrum cephalosporins of Providencia spp. and K. aerogenes strains exceeded 50%, and resistance to meropenem over 10% was observed only in C. freundii strains. Enterobacterales' ever-growing resistance to antibiotics is becoming quite a challenge for clinicians and new treatment options are required.
Databáze: MEDLINE